Jenna Wilke, NP
Articles
Frontline Treatment and Molecular Testing in Upper GI Cancer: Precision-Guided Therapy
David Zhen, MD;Nataliya V. Uboha, MD, PhD;Samuel Cytryn, MD;Leslie Swanson, NP;Claudia Calderon, NP;Jenna Wilke, NP
February 28th 2025Experts discuss frontline treatment options for advanced upper gastric adenocarcinoma, molecular testing methods, challenges encountered, and how test results influence the choice of systemic therapy for patients.
Robert’s Journey With HER2 Upper GI Cancer
David Zhen, MD;Nataliya V. Uboha, MD, PhD;Samuel Cytryn, MD;Leslie Swanson, NP;Claudia Calderon, NP;Jenna Wilke, NP
February 28th 2025Experts discuss Robert’s journey with HER2-positive upper gastrointestinal (GI) cancer, highlighting key treatment approaches and challenges.
Latest Updated Articles
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: August 26th 2011 | Updated: March 1st 2025
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
